Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial

Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Mar 13, 2024

Keywords

ClinConnect Summary

The CUSP2CT Project at Ohio State University is a clinical trial aimed at improving the participation of underrepresented racial and ethnic groups in cancer clinical trials. The trial is important because it seeks to address the inequalities in cancer research participation, which can slow down the development of better treatments for everyone. By focusing on communities that are often left out of these studies, the project hopes to enhance how many people from diverse backgrounds can be referred to and enrolled in clinical trials related to cancer prevention and treatment.

To be eligible for this trial, participants should be from specific counties in the Ohio State University Comprehensive Cancer Center area. The project will involve patients, healthcare providers, and hospitals, working together to tackle the challenges that prevent diverse populations from participating in clinical research. If you or someone you know is interested in participating, you can expect to be part of a community effort to ensure that more voices are heard in cancer research, helping to create a future where everyone has equal access to the latest advancements in cancer care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Phase I: 9 counties in the OSUCCC catchment area
• • Phase II: Patients, providers, and hospital systems/referral centers that directly addresses challenges identified in Phase I
• • Phase II: The project will involve the OSUCCC, the OSU James Cancer Network sites and the Columbus and Dayton NCORP sites